CXCL9 and 11 in patients with pulmonary sarcoidosis: A role of alveolar macrophages

Clinical and Experimental Immunology

Volumn 149, Issue 2, 2007, Pages 317-326

  Nishioka, Y ^a   Manabe, K ^a   Kishi, J ^a   Wang, W ^a   Inayama, M ^a   Azuma, M ^a   Sone, S ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Alveolar macrophages; CXCL10; CXCL11; CXCL9; Sarcoidosis

Indexed keywords

CHEMOKINE; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIOID CELL; FEMALE; GIANT CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SARCOIDOSIS; TH1 CELL;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES, CXC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIGANDS; LUNG; LYMPHOCYTE COUNT; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SARCOIDOSIS, PULMONARY; SEVERITY OF ILLNESS INDEX;

EID: 34447309559     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03423.x     Document Type: Article

References (33)

1. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and Other Granulomatous Disorders. Statement on sarcoidosis. Am J Respir Crit Care Med 1999 160 : 736 55.
2. Costabel U. Sarcoidosis: clinical update. Eur Respir J 2001 18 : s56 68.
3. Baughman RP, Lower EE, du Bois R. Sarcoidosis. Lancet 2003 361 : 1111 18.
4. Nunes H, Soler P, Valeyre D. Pulmonary sarcoidosis. Allergy 2005 60 : 565 82.
5. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988 167 : 219 24.
6. Wahlstrom J, Katchar K, Wigzell H, Olerup O, Eklund A, Grunewald J. Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis. Am J Respir Crit Care Med 2001 163 : 115 21.
7. Prasse A, Georges CG, Biller H et al. Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells. Clin Exp Immunol 2000 122 : 241 8.
8. Bergeron A, Bonay M, Kambouchner M et al. Cytokine patterns in tuberculous and sarcoid granulomas: correlation with histopathologic features of the granulomatous response. J Immunol 1997 159 : 3034 43.
9. Bonecchi R, Bianchi G, Bordignon PP et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998 187 : 129 34.
10. Capelli A, di Stefano A, Lusuards M, Gnemmi I, Donner CF. Increased macrophage inflammatory protein-1α and macrophage inflammatory protein-1β levels in bronchoalveolar lavage fluid of patients affected by different stages of pulmonary sarcoidosis. Am J Respir Crit Care Med 2002 165 : 236 41.
11. Agostini C, Cassatella M, Zambello R et al. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. J Immunol 1998 161 : 6413 20.
12. Katchar K, Eklund A, Grunewald J. Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis. J Intern Med 2003 254 : 564 71.
13. Miotto D, Christodoulopoulos P, Olivenstein R et al. Expression of IFN-γ-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung disease. J Allergy Clin Immunol 2001 107 : 664 70.
14. Tani K, Ogushi F, Huang L, Kawano T, Tada H, Hariguchi N, Sone S. CD13/aminopeptidase N, a novel chemoattractant for T lymphocytes in pulmonary sarcoidosis. Am J Respir Crit Care Med 2000 161 : 1636 42.
15. Manabe K, Nishioka Y, Kishi J et al. Elevation of macrophage-derived chemokine in eosinophilic pneumonia: a role of alveolar macrophages. J Med Invest 2005 52 : 85 92.
16. Nishioka Y, Yano S, Fujiki F et al. Combined therapy of multidrug-resistant human lung cancer with anti-P-glycoprotein antibody and monocyte chemoattractant protein-1 gene transduction: the possibility of immunological overcoming of multidrug resistance. Int J Cancer 1997 71 : 170 7.
17. Farber JM. A macrophage mRNA selectively induced by γ-interferon encodes a member of the platelet factor 4 family of cytokines. Proc Natl Acad Sci USA 1990 87 : 5238 42.
18. Luster AD, Unkeless JC, Ravetch JV. γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 1985 315 : 672 6.
19. Cole KE, Strick CA, Paradis TJ et al. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 1998 187 : 2009 21.
20. Goto H, Yano S, Zhang H et al. Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice. Cancer Res 2002 62 : 3711 5.
21. Zhao DX-M, Hu Y, Miller GG, Luster AD, Mitchell RN, Libby P. Differential expression of the IFN-γ-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell α chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection. J Immunol 2002 169 : 1556 60.
22. Nishioka Y, Nishimura N, Suzuki Y, Sone S. Human monocyte-derived and CD83+ blood dendritic cells enhance NK cell-mediated cytotoxicity. Eur J Immunol 2001 31 : 2633 41.
23. Hildebrandt GC, Corrion LA, Olkiewicz KM et al. Blockade of CXCR3 receptor : ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome. J Immunol 2004 173 : 2050 9.
24. Nance S, Cross R, Fitzpatrick E. Chemokine production during hypersensitivity pneumonitis. Eur J Immunol 2004 34 : 677 85.
25. Belperio JA, Keane MP, Burdick MD et al. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol 2002 169 : 1037 49.
26. Pignatti P, Brunetti G, Moretto D et al. Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis. Am J Respir Crit Care Med 2006 173 : 310 7.
27. Shigehara K, Shijubo N, Ohmichi M et al. Increased levels of interleukin-18 in patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 2000 162 : 1979 82.
28. Takeuchi M, Oh IK, Suzuki J et al. Elevated serum levels of CXCL9/monokine induced by interferon-γ and CXCL10/interferon-γ- inducible protein-10 in ocular sarcoidosis. Invest Ophthalmol Vis Sci 2006 47 : 1063 8.
29. Shigehara K, Shijubo N, Ohmichi M et al. IL-12 and IL-18 are increased and stimulate IFN-γ production in sarcoid lungs. J Immunol 2001 166 : 642 9.
30. Koura T, Gon Y, Hashimoto S et al. Expression of thioredoxin in granulomas of sarcoidosis: possible role in the development of T lymphocyte activation. Thorax 2000 55 : 755 61.
31. Marx N, Mach F, Sauty A et al. Peroxisome proliferator-activated receptor-γ activators inhibit IFN-γ-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J Immunol 2000 164 : 6503 8.
32. Sauty A, Dziejman M, Taha RA et al. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol 1999 162 : 3549 58.
33. Agostini C, Cabrelle A, Calabrese F et al. Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T cell alveolitis in sarcoidosis. Am J Respir Crit Care Med 2005 172 : 1290 8.